Evidence map›Paper›PMID 34992858›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2021

Radiotherapy as treatment option in biliary cancer patients: a national survey of AIRO (Italian Association of Radiation Oncology) Gastroenterology Group.

Valentina Lancellotta, Mattia Falchetti Osti, Giancarlo Mattiucci, Alessio Morganti, Vittorio Bini, Cynthia Aristei, Marco Lupattelli

Open access · diamondAbstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Valentina LancellottaRadiation Oncology Department, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
Mattia Falchetti OstiDepartment of Radiation Oncology, Sant'Andrea Hospital, Rome, Italy.
Giancarlo MattiucciRadiation Oncology Department, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
Alessio MorgantiRadiation Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine, DIMES, University, S. Orsola-Malpighi Hospital, Bologna, Italy.
Vittorio BiniInternal Medicine, Endocrine and Metabolic Science Section, University of Perugia, Italy.
Cynthia AristeiRadiation Oncology Section, Department of Surgical and Biomedical Sciences, University and General Hospital, Perugia, Italy.
Marco LupattelliRadiation Oncology Section, General Hospital, Perugia, Italy.
University of Perugia · ITAgostino Gemelli University Polyclinic · ITCTO Andrea Alesini · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITPoliclinico S.Orsola-Malpighi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim is to find out how many radiation oncology centres treat biliary duct carcinoma (BDC), what treatments they offer and whether they would be interested in developing prospective trials. MATERIALS AND

methodsA questionnaire was posted to all 220 Italian Radiation Oncology Centres. The survey consisted of 31 eligibility questions in a combination of multiple and forced choice formats addressing the following parameters: characteristics of the centre, numbers of BDC patients treated, treatment options, radiotherapy parameters (target definition, schedule, technique, dose constraints) and interest in developing future randomized trials.

resultsNo major differences emerged in BDC management, whatever the site, and whether it was resectable or not. Discrepancies in routine clinical practice were, however, observed with lack of agreement on expansion margins, dose constraints and treatment schedules for the stereotactic technique and palliative treatments.

conclusionsThe present survey attempted to fill the gaps in the role of radiotherapy in patients with BDC. Since lack of prospective randomized studies and disease rarity have mitigated against an evidence-based approach, patients with BDC should be enrolled in prospective studies. The above-mentioned results should also emphasize the need to combine analysis of treatment results from all Italian centres in order to create predictive models.

Indexed as

abdomen irradiationbrachytherapychemoradiotherapy

Identifiers

PMID34992858
PMCPMC8726438
OpenAlexW3194300991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.